CELLinCELLS provides innovative solutions based on cell therapy technology to enhance quality of life and improve human health.
04.Expansion of Pipeline for IND (Investigational New Drug) Application
· Pipeline for Rare/Unmet Diseases: Clinical Research/Therapeutic Research
- Arthritis (Injectable), Meniscus Injury, Frozen Shoulder, Skeletal Muscle, etc.
* Fast market entry through accelerated approval, customized review, and conditional approval based on the Advanced Regenerative Medicine and Advanced Biopharmaceuticals Act (AMRAB).
CELLinCELLS provides innovative solutions based on cell therapy technology to enhance quality of life and improve human health.
2nd Floor, Room 203, 240-39 Changgyeonggung-ro, Jongno-gu, Seoul, South Korea (Gwangwon Building, Myeongnyun 4-ga)
TEL +82-2-742-0032 FAX +82-2-764-7300
Room 501, Biomaterials Research Building, 101 Daehak-ro, Jongno-gu, Seoul, South Korea (Seoul National University School of Dentistry)
TEL +82-2-740-8641 FAX +82-2-742-8666
Room 523, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea (Teratower, Munjeong Station)
TEL +82-2-742-0032 FAX +82-2-764-7300
Rooms 513–515, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea (Teratower, Munjeong Station)
TEL +82-2-742-0032 FAX +82-2-764-7300
2nd Floor, Room 203, 240-39 Changgyeonggung-ro, Jongno-gu, Seoul, South Korea (Gwangwon Building, Myeongnyun 4-ga)
TEL +82-2-742-0032
FAX +82-2-764-7300
Room 501, Biomaterials Research Building, 101 Daehak-ro, Jongno-gu, Seoul, South Korea
(Seoul National University School of Dentistry)
TEL +82-2-740-8641
FAX +82-2-742-8666
Room 523, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea
(Teratower, Munjeong Station)
TEL +82-2-742-0032
FAX +82-2-764-7300
Rooms 513–515, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea
(Teratower, Munjeong Station)
TEL +82-2-742-0032
FAX +82-2-764-7300
office@cellincells.com
Copyrights © 2025 CELLinCELLS co.,Ltd. All Rights Reserved.